The CNS Summit Pharma Innovation Index
Launched at CNS Summit 2016, the CNS Summit Pharma Innovation Index, developed in collaboration with IDEA Pharma, ranks life science companies developing new treatments, based on publicly available information, with regards to three facets of innovation:
- Technology Advancement
- Trial Optimization
- Innovative Partnerships
The goal of the Innovation Index is to objectively assess the investments being made in innovation, encourage innovation, and allow companies to benchmark their innovation activities via an objective external source.
To learn more about the Index and which companies will measure up in 2021, register for the year-round 2021 CNS Summit